국가: 오스트레일리아
언어: 영어
출처: Department of Health (Therapeutic Goods Administration)
latanoprost, Quantity: 0.05 mg/mL
Sandoz Pty Ltd
Latanoprost
Eye Drops, solution
Excipient Ingredients: sodium chloride; dibasic sodium phosphate; benzalkonium chloride; water for injections; monobasic sodium phosphate monohydrate
Ophthalmic
1
(S4) Prescription Only Medicine
Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Visual Identification: Each 5mL LDPE bottle contains 2.5mL clear colourless eye drop solution.; Container Type: Bottle; Container Material: LDPE; Container Life Time: 24 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Restricted flow insert
Licence status A
2017-09-29
LATANOPROST SANDOZ ® 1 LATANOPROST SANDOZ ® _Latanoprost Eye Drops Solution _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Latanoprost Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT LATANOPROST SANDOZ IS USED FOR This medicine is used to treat lower raised pressure in the eye and to treat glaucoma. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye. There are usually no symptoms of glaucoma. If glaucoma is not treated it can lead to serious problems, including total blindness. In fact, untreated glaucoma is one of the most common causes of blindness. _ _ _HOW LATANOPROST SANDOZ _ _WORKS_ _ _ It contains the active ingredient latanoprost. Latanoprost belongs to a group of medicines called prostaglandin agonists. It works by lowering the pressure in the eye by allowing more fluid to flow out from within your eye. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescrib 전체 문서 읽기
200422-latanoprost sandoz-pi Page 1 of 13 AUSTRALIAN PRODUCT INFORMATION LATANOPROST SANDOZ ® (LATANOPROST) EYE DROPS, SOLUTION 1. NAME OF THE MEDICINE Latanoprost 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Latanoprost Sandoz Eye Drops is a sterile, isotonic solution containing 50 micrograms/mL of latanoprost in an aqueous solution of pH 6.7. Each 5 mL polyethylene bottle contains 2.5 mL clear colourless eye drop solution corresponding to a minimum of 80 drops of solution. One drop contains approximately 1.5 micrograms latanoprost. _Excipients with known effect:_ benzalkonium chloride. For the full list of excipients, see Section 6.1 List of excipients. 3. PHARMACEUTICAL FORM Eye drops, solution. The solution is a clear and colourless liquid, filled in a polyethylene container. 4. CLINICAL PARTICULARS 4.1. T HERAPEUTIC INDICATIONS Reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. 4.2. D OSE AND METHOD OF ADMINISTRATION DOSAGE _RECOMMENDED DOSAGE FOR ADULTS (INCLUDING THE ELDERLY) _ Recommended therapy is one eye drop in the affected eye(s) once daily. Optimal effect is obtained if Latanoprost Sandoz is administered in the evening. Systemic absorption can be minimised by pressure on the tear duct immediately after application of the eye drop. If one dose is missed, treatment should continue with the next dose as normal. The dosage of Latanoprost Sandoz should not exceed once daily since it has been shown that more frequent administration decreases the intraocular pressure lowering effect. METHOD OF ADMINISTRATION Latanoprost Sandoz is effective as a single drug therapy but can also be used in combination with beta-adrenergic antagonists (timolol), adrenergic agonists (dipivefrine hydrochloride), cholinergic agonists (pilocarpine) and carbonic anhydrase inhibitors (acetazolamide) to achieve an additive effect. In case of combined therapy the eye drop products should be administered with an interval of at least five minutes. 200422-latanoprost sandoz-pi Page 2 전체 문서 읽기